The startup operates a biotechnology research facility that provides clients with access to shared and private laboratory spaces, including a mouse vivarium, to facilitate the development of therapies. By offering experienced research managers and affordable research infrastructure, the company enables clients to efficiently conduct preclinical studies and accelerate their drug development processes.
Funding
$6.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Early-stage life science companies often face challenges in accessing specialized laboratory facilities and expertise needed for preclinical research and development. The high costs of establishing and maintaining a fully equipped lab, along with the need for experienced research personnel, can be a significant barrier to developing innovative therapies.
Solution
K2bio is a hybrid Contract Research Organization (CRO) that provides early-stage life science companies with access to state-of-the-art laboratory space, equipment, and experienced research staff to accelerate preclinical studies. K2bio offers both shared and private lab spaces, including an on-site vivarium, enabling clients to conduct research in a cost-effective and efficient manner. The company's services range from study design and execution to data analysis and regulatory support, covering in vitro and in vivo studies. K2bio's team provides guidance and phase-appropriate regulatory oversight throughout the product research and development lifecycle, helping clients navigate the complexities of preclinical development and bridge the gap between bench and commercialization.
Target Audience
K2bio serves early-stage biopharmaceutical companies, researchers, and pharmaceutical companies seeking to outsource preclinical research and development activities, access specialized facilities and equipment, and accelerate their drug development timelines.
Features
- Premium lab space with essential reagents and equipment, including refrigerators, freezers, cryo-storage, incubators, centrifuges, and microscopes
- On-site vivarium staffed by experienced personnel for in vivo studies
- Comprehensive in vitro services, including cell-based assays, immunoassays, and reporter cell line development
- In vivo capabilities, including anti-tumor efficacy models, PK/PD studies, and toxicology assessments
- Histology services, including tissue processing, embedding, sectioning, and staining
- Single-cell in situ analysis using 10x Genomics Xenium technology for spatial transcriptomics and cell-cell interaction studies
- Analytical development services, including process optimization, analysis, and product manufacturability assessments according to cGMP
- Consulting services, including quality assurance (QA) and chemistry, manufacturing, and controls (CMC) support